Ace (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans

Circulation

Volumn 98, Issue 20, 1998, Pages 2148-2153

  Ueda, Shinichiro ^a,b   Meredith, Peter A ^a   Morton, James J ^a   Connell, John M C ^a   Elliott, Henry L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Angiotensin; Enalaprilat; Enzymes; Genes

Indexed keywords

ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; GENE PRODUCT; PLACEBO;

ADULT; ALLELE; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; GENETIC POLYMORPHISM; GENOTYPE; HEART FAILURE; HOMOZYGOSITY; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0032542030     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.20.2148     Document Type: Article

References (28)

1. Brunner HR, Gavras H, Waeber B, Textor SC, Turini CA, Wauters JP. Clinical use of an orally active converting enzyme inhibitor: captopril. Hypertension. 1980;2:558-566.
2. Hodsman GP, Brown JJ, Davies DL. Converting enzyme inhibitor enalapril in treatment of hypertension with renal artery stenosis. BMJ. 1982; 285:1697-1699.
3. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Co-operative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316:1429-1435.
4. Donnelly R, Meredith PA, Elliott HL. The description and prediction of antihypertensive drug response: an individualised approach. Br J Clin Pharmacol. 1991;31:627-634.
5. Gavras H, Brunner HR, Turini GA, Kershaw GR, Tifft CP, Cuttelod S, Gavras I, Vukovich RA, McKinstry DN. Antihypertensive effect of the oral angiotensin converting enzyme inhibitor SQ14225 (captopril) in man. N Engl J Med. 1978;278:991-995.
6. Cody RJ, Laragh JH, Case DB, Atlas SA. Renin system activity as a determinant of response to treatment in hypertension and heart failure. Hypertension. 1983;5(suppl III):36-42.
7. MacFadyen RJ, Elliott HL, Meredith PA, Reid JL. Haemodynamic and hormonal responses to oral enalapril in salt depleted normotensive man. Br J Clin Pharmacol. 1993;35:299-301.
8. Donnelly R, Meredith PA, Elliott HL, Reid JL. Kinetic-dynamic relations and individual responses to enalapril. Hypertension. 1990;15:301-309.
9. Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med. 1991;117:33-39.
10. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197-205.
11. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
12. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J. 1993;290: 33-40.
13. Danser AHJ, Schalekamp ADH, Bax WA, Brink AMVD, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin-converting enzyme in the human heart. Circulation. 1995;92:1387-1388.
14. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Aveiler D, Luc E, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene of angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359: 641-644.
15. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischaemic heart disease. N Engl J Med. 1995;332:706-711.
16. Harden PN, O'Kane KPJ, Ueda S, Connell JMC, Jardine AG. Association studies, ACE polymorphism and renal disease. Nephrol Dial Transplant. 1996;11:757-759.
17. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 1994;94:978-984.
18. Ueda S, Elliott HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive men with deletion genotype (DD) for angiotensin-converting enzyme. Hypertension. 1995;25:1266-1269.
19. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase I). Nucl Acid Res. 1992; 20:1433.
20. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, O'Rourke DF, Cambien F. Polymorphism of the angiotensin-converting enzyme gene in subjects who die from coronary heart disease. Q J Med. 1994;87:211-214.
21. Sumner DJ, Elliott HL, Vincent J, Reid JL. A pragmatic approach to the pressor dose response as an index of vascular reactivity and adrenoreceptor function in man. Br J Clin Pharmacol. 1987;23:505-510.
22. Morton JJ, Webb DJ. Measurement of plasma angiotensin II. Clin Sci. 1985;68:483-484.
23. McKenzie JK, Clements JA. Simplified radioimmunoassay for serum aldosterone utilising increased antibody specificity. J Clin Endocrinol Metab. 1974;38:622-627.
24. Millar JA, Leckie BJ, Morton JJ, Jordan J, Tree M. A micro-assay for active and total renin concentration in human plasma based on antibody trapping. Clin Chem Acta. 1980;101:5-15.
25. Chiknas SG. A liquid chromatography-assisted assay for angiotensin-converting enzyme (peptidyl dipeptidase) in serum. Clin Chem. 1979;25: 1259-1262.
26. Hichens M, Hand EL, Mulcahy WS. Radioimmunoassay of angiotensin converting enzyme inhibitors. Ligand Q. 1981;4:43.
27. Jeunemaitre X, Chatellier G, Alhenc-Gelas F, Charm A, Dumont C, Sassano P, Corvol P, Menard J. Relation between the insertion/deletion (I/D) polymorphism of the angiotensin I converting enzyme gene and chronic clinical and biological variations induced by enalapril. J Hypertens. 1994;12(suppl 3):S154. Abstract.
28. Cambien F, Cousterousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Soubrier F, Alhenc-Gelas F. Plasma levels and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.